Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 27, 2016
Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromesXavier Calvo, Leonor Arenillas, Elisa Luño, et al.American Journal of Hematology|April 4, 2017
Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R)Xavier Calvo, Leonor Arenillas, Elisa Luño, et al.Haematologica|July 20, 2004
Feasibility and results of autologous stem cell transplantation in de novo acute myeloid leukemia in patients over 60 years old. Results of the CETLAM AML-99 protocolAlbert Oriol, Josep-Maria Ribera, Jordi Esteve, et al.Haematologica|January 29, 2008
High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphomaSilvia Montoto, Carol Moreno, Eva Domingo-Doménech, et al.British Journal of Haematology|September 11, 2012
Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromesSílvia Saumell, Lourdes Florensa, Elisa Luño, et al.American Journal of Hematology|November 19, 2016
Excess mortality in the myelodysplastic syndromesMeritxell Nomdedeu, Arturo Pereira, Fernando Ramos, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic SyndromesLeonor Arenillas, Xavier Calvo, Elisa Luño, et al.Annals of Hematology|August 10, 2012
Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survivalCarlos Santamaría, Fernando Ramos, Noemi Puig, et al.Leukemia Research|December 17, 2013
Transfusion dependence development and disease evolution in patients with MDS and del(5q) and without transfusion needs at diagnosisSilvia M Rojas, María Díez-Campelo, Elisa Luño, et al.Genes, Chromosomes & Cancer|October 15, 2013
Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testingLeonor Arenillas, Mar Mallo, Fernando Ramos, et al.Pageof 3